Immunarray vs MeMed
Immunarray vs MeMed, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunarray is on 39/100 and MeMed on 61/100.
Where each one leads
Immunarray
Leads on none of the measures we hold for both companies.
MeMed
- our overall score: 61/100 against 39/100
- agent readiness: 35/100 against 28/100
- domain rating: 46/100 against 18/100
- funding raised: $196M against $10.0M
At a glance
| Measure | Immunarray | MeMed |
|---|---|---|
| What it is | ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform. | MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes. |
| Category | Healthcare, Blood, Diagnostics, Immunology | Healthcare, Blood, Diagnostics, MedTech |
| Sells toBusiness model | B2B | B2B, B2G |
| Offering | Software | Software, Hardware |
| Founded | 2006 | 2009 |
| Headquarters | Richmond, United States | Tirat Carmel, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Immunarray | MeMed |
|---|---|---|
| Employees | Not published | 99 |
| Headcount growthLast 12 months | Not published | -8.4% |
| Total funding | $10.0M | $196M |
| Latest round | Series A | Series E |
| LinkedIn followers | Not published | 21,207 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunarray | MeMed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 61/100 |
| Traction | 35/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Community | 13/100 | Not published |
| Search visibility | 5/100 | 29/100 |
| Quality | 45/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (28/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 18/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunarray | MeMed |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
Immunarray vs MeMed: common questions
Which is better, Immunarray or MeMed?
On our 0-100 score MeMed rates higher (61/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Immunarray and MeMed compare on the numbers?
MeMed leads on our overall score (61/100 against 39/100), agent readiness (35/100 against 28/100), domain rating (46/100 against 18/100), funding raised ($196M against $10.0M).
Read the full Immunarray review and pricing or the MeMed review and pricing. You can also browse other Immunarray alternatives we track.